Pfizer’s bowel disease drug succeeds in second late-stage study
Pfizer's etrasimod showed improvement in patients with moderate-to-severe ulcerative colitis after 52 weeks. It met the twin main…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.